esketamine news

All news on esketamine (also known as (S)-Ketamine and SPRAVATO): plants, production capacities, investments and involved companies.

8 September 2026

Johnson & Johnson to present neuropsychiatry data at Psych Congress 2026

24 abstracts at Psych Congress will report Phase 3 CAPLYTA data in bipolar mania, SPRAVATO analyses on anhedonia, seltorexant MDD+insomnia results, and LAI real‑world studies.

Who will be producing esketamine in the future?

Find out with chemXplore Alpha

Learn more